Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan.
Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan.
World Neurosurg. 2022 Nov;167:e575-e582. doi: 10.1016/j.wneu.2022.08.053. Epub 2022 Aug 19.
Among dystonia patients receiving globus pallidus internus (GPi) deep brain stimulation (DBS), long-term outcomes remain to be established. To report the long-term outcomes of GPi DBS in a patient cohort with idiopathic and acquired dystonia.
In this long-term follow-up cohort, there were 4 patients with idiopathic dystonia and 2 patients with acquired dystonia. The Burke-Fahn-Marsden Dystonia Rating Scale was used to evaluate 6 consecutive patients preoperatively and at 6 months, 12 months, and the last follow-up. The relationship between etiology and clinical improvement was analyzed. Stimulation parameters were evaluated for similarities and differences among these patients.
The mean follow-up of our cohort was 65.3 months (median 40.5 months). The average improvement in the Burke-Fahn-Marsden Dystonia Rating Scale (mean ± SEM) were 56% ± 7.6, 67% ± 6.8 and 66% ± 9.7 at 6 months, 12 months, and the last follow-up, respectively. There was greater improvement during the long-term follow-up in the 4 patients with idiopathic dystonia than in the 2 patients with acquired dystonia. The 2 most ventral electrodes (contact 0 and 1) were activated in all 11 leads in this cohort. The average stimulation intensity, pulse width and frequency were 2.0 ± 0.24 mA, 252 ± 43 μs, and 99 ± 6.0 Hz, respectively.
Isolated dystonia, either monogenic or idiopathic, usually responds better to GPi DBS than to acquired dystonia. Selection of patients by dystonia etiology, accurate placement of DBS leads in GPi targets, and proper stimulation programming are crucial to achieve better long-term outcomes.
在接受苍白球内侧(GPi)深部脑刺激(DBS)的肌张力障碍患者中,长期疗效仍有待确定。本研究旨在报告特发性和获得性肌张力障碍患者接受 GPi-DBS 治疗的长期结果。
在这项长期随访的队列研究中,有 4 例特发性肌张力障碍患者和 2 例获得性肌张力障碍患者。使用 Burke-Fahn-Marsden 肌张力障碍评定量表(BFMDRS)对 6 例连续患者术前、术后 6 个月、12 个月和最后一次随访时进行评估。分析病因与临床改善之间的关系。评估这些患者之间刺激参数的相似性和差异性。
本队列的平均随访时间为 65.3 个月(中位数 40.5 个月)。BFMDRS 的平均改善(均值±SEM)分别为:术后 6 个月 56%±7.6、术后 12 个月 67%±6.8 和最后一次随访时 66%±9.7。4 例特发性肌张力障碍患者的长期随访改善程度大于 2 例获得性肌张力障碍患者。本队列所有 11 个导联均激活了最靠近腹侧的 2 个电极(触点 0 和 1)。平均刺激强度、脉冲宽度和频率分别为 2.0±0.24mA、252±43μs 和 99±6.0Hz。
孤立性肌张力障碍,无论是单基因还是特发性,通常对 GPi-DBS 的反应优于获得性肌张力障碍。根据病因选择患者,将 DBS 电极准确放置在 GPi 靶点内,并进行适当的刺激编程,对获得更好的长期疗效至关重要。